Table 2 Minimum inhibitory and minimum bactericidal concentrations in μg/ml of benzalkonium with and without thymoquinone supplementation.
From: Antibacterial and resistance-modifying activities of thymoquinone against oral pathogens
Strains | MIC BC | MBC BC | aMIC BC + 1/2MIC TQ | aMBC BC +1/2 MIC TQ |
|---|---|---|---|---|
References strains | ||||
B. cereus ATCC 14579 | 16 | 32 | 4 (4) | 8 (4) |
E. coli ATCC 35218 | 16 | 32 | 16 (NC) | 16 (2) |
E. faecalis ATCC 29212 | 8 | 16 | 4 (2) | 4 (4) |
L. monocytogenes ATCC 19115 | 1 | 4 | 1 (NC) | 2 (2) |
M. luteus NCIMB 8166 | 16 | 16 | 2 (8) | 4 (4) |
S. enterica serovar Typhimurium ATCC 1408 | 32 | 64 | 32 (NC) | 64 (NC) |
S. aureus ATCC 25923 | 16 | 32 | 2 (8) | 4 (8) |
S. epidermidis CIP 106510 | 4 | 8 | 2 (2) | 4 (2) |
P. aeruginosa ATCC 27853 | 128 | 256 | 128 (NC) | 256 (NC) |
V. alginolyticus ATCC 33787 | 32 | 64 | 16 (2) | 32 (2) |
V. paraheamolyticus ATCC 17802 | 32 | 128 | 4 (8) | 16 (8) |
Oral strains | ||||
E. faecalis B281 | 256 | >256 | 256 (NC) | >256 (NC) |
Gemella haemolysans B234 | 8 | 32 | 4 (2) | 8 (4) |
S. aureus B73 | 16 | 32 | 2 (8) | 8 (4) |
S. aureus B285 | 8 | 16 | 2 (4) | 4 (4) |
S. aureus B291 | 16 | 16 | 2 (2) | 4 (4) |
S. aureus B289 | 8 | 16 | <1 (>8) | 2 (8) |
S. aureus B456 | 4 | 8 | <1 (>8) | 2 (4) |
S. aureus B244 | 2 | 8 | <1 (>8) | 2 (4) |
S. aureus B364 | 64 | 128 | 8 (>8) | 32 (4) |
S. aureus B398 | 4 | 8 | <1 (>8) | 2 (4) |
S. anginosus B486 | 8 | 16 | 4 (2) | 8 (2) |
S. constellatus B629 | 4 | 16 | 2 (2) | 4 (4) |
S. mitis B627 | 4 | 8 | 4 (NC) | 16 (2) |
S. mutans B509 | 4 | 8 | 2 (2) | 4 (2) |
S. oralis B634 | >256 | >256 | >256 (NC) | >256 (NC) |
S. salivarius B468 | 8 | 16 | 4 (2) | 8 (2) |